Medicare Enrolled
Dr. Jumana Chatiwala, M.D.
Internal Medicine · Sparta, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chatiwala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chatiwala?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chatiwala
Dr. Jumana Chatiwala is an internal medicine specialist in Sparta, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chatiwala performed 171,705 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Chatiwala received a total of $17,204 from 65 pharmaceutical and/or device companies across 311 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chatiwala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 0% volume in NJ
$17,204 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗171,705
Medicare services
Top 0% in NJ for internal medicine
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
51,750 | $1 | $4 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
24,400 | $0 | $15 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
14,300 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 10,270 | $1 | $8 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
9,540 | $0 | $1 |
| Paclitaxel chemotherapy injection | 8,364 | $0 | $1 |
| Pembrolizumab injection (Keytruda) | 7,800 | $43 | $133 |
| Denosumab injection (Prolia/Xgeva) | 6,660 | $19 | $62 |
| Iron infusion (Monoferric) | 5,100 | $17 | $69 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,710 | $0 | $1 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
4,440 | $6 | $49 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,140 | $1 | $95 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,918 | $8 | $32 |
| Injection, atropine sulfate, 0.01 mg | 2,280 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,926 | $105 | $231 |
| Injection, leucovorin calcium, per 50 mg | 1,674 | $3 | $22 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,325 | $8 | $18 |
| Pegfilgrastim-cbqv injection An injection of pegfilgrastim-cbqv, a biosimilar medication, administered at a dose of 0.5 mg. |
1,212 | $109 | $877 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
1,097 | $26 | $128 |
| Anti-nausea injection (ondansetron/Zofran) | 1,020 | $0 | $3 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
901 | $2 | $10 |
| Injection, irinotecan, 20 mg | 846 | $2 | $154 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
582 | $119 | $566 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
432 | $14 | $88 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
420 | $12 | $81 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
405 | $68 | $157 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
342 | $25 | $122 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
336 | $2 | $196 |
| Injection, potassium chloride, per 2 meq | 310 | $0 | $1 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
253 | $59 | $272 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
227 | $59 | $279 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
220 | $1 | $5 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
210 | $1 | $15 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
187 | $18 | $74 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
185 | $1 | $6 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
168 | $65 | $198 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
159 | $136 | $351 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
139 | $20 | $58 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
136 | $151 | $310 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
120 | $111 | $297 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
110 | $4 | $24 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
108 | $51 | $224 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
101 | $1 | $15 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
97 | $19 | $82 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
96 | $158 | $784 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
95 | $30 | $113 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
90 | $11 | $68 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
90 | $22 | $91 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
82 | $95 | $261 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
75 | $1 | $14 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
69 | $77 | $152 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
62 | $83 | $247 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
50 | $29 | $216 |
| New patient office visit, complex (60-74 min) | 24 | $184 | $444 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
20 | $66 | $177 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $45 | $97 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
14 | $136 | $507 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
34.6% high complexity
60.8% medium
4.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,204
Total received (2018-2024)
Avg $2,458/year across 7 years
Top 4% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
311
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,466
2023
$1,585
2022
$628
2021
$395
2020
$514
2019
$7,883
2018
$4,733
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$1,143
GlaxoSmithKline, LLC.
$37
Astellas Pharma US Inc
$37
PFIZER INC.
$35
Novartis Pharmaceuticals Corporation
$33
Regeneron Healthcare Solutions, Inc.
$31
E.R. Squibb & Sons, L.L.C.
$28
Lilly USA, LLC
$22
Apellis Pharmaceuticals, Inc.
$18
Pharmacosmos Therapeutics Inc.
$17
EMD Serono, Inc.
$17
Genentech USA, Inc.
$17
Janssen Biotech, Inc.
$16
Celgene Corporation
$14
Top 3 companies account for 83.1% of 2024 payments
All-time payments by company (2018-2024) ›
Cornerstone Specialty Network LLC
$3,595
AMAG Pharmaceuticals, Inc.
$3,197
Mylan Institutional Inc.
$2,651
AstraZeneca Pharmaceuticals LP
$1,357
Janssen Biotech, Inc.
$1,126
Coherus Biosciences Inc.
$1,088
Novartis Pharmaceuticals Corporation
$429
Amgen Inc.
$351
PFIZER INC.
$337
Merck Sharp & Dohme Corporation
$275
E.R. Squibb & Sons, L.L.C.
$273
Astellas Pharma US Inc
$215
Genentech USA, Inc.
$208
Heron Therapeutics, Inc.
$186
Lilly USA, LLC
$156
Celgene Corporation
$106
GlaxoSmithKline, LLC.
$100
Bayer HealthCare Pharmaceuticals Inc.
$91
Merck Sharp & Dohme LLC
$80
Regeneron Healthcare Solutions, Inc.
$78
Pharmacyclics LLC, An AbbVie Company
$74
Takeda Pharmaceuticals U.S.A., Inc.
$69
Gilead Sciences, Inc.
$67
Incyte Corporation
$59
Ipsen Biopharmaceuticals, Inc
$58
Seagen Inc.
$55
EMD Serono, Inc.
$55
Mirati Therapeutics, Inc.
$54
Kite Pharma, Inc.
$52
AbbVie, Inc.
$52
GENZYME CORPORATION
$40
Alexion Pharmaceuticals, Inc.
$39
Pharmacosmos Therapeutics Inc.
$34
Kyowa Kirin, Inc.
$29
Janssen Pharmaceuticals, Inc
$29
Genmab U.S., Inc.
$29
EISAI INC.
$29
Daiichi Sankyo Inc.
$28
Pharmacyclics LLC, an AbbVie Company
$27
MEDIVATION FIELD SOLUTIONS LLC
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Stemline Therapeutics Inc.
$20
Myriad Genetic Laboratories, Inc.
$20
Myovant Sciences Inc.
$18
Apellis Pharmaceuticals, Inc.
$18
Acrotech Biopharma LLC
$17
TESARO, Inc.
$17
Dova Pharmaceuticals
$17
Adaptive Biotechnologies Corporation
$16
MACROGENICS, INC.
$16
ARRAY BIOPHARMA INC
$16
Cumberland Pharmaceuticals, Inc.
$16
Otsuka America Pharmaceutical, Inc.
$16
Servier Pharmaceuticals LLC
$15
AbbVie Inc.
$15
Seattle Genetics, Inc.
$15
TerSera Therapeutics LLC
$15
CTI BioPharma Corp.
$15
Eisai Inc.
$14
ImmunoGen, Inc.
$14
Rigel Pharmaceuticals, Inc.
$13
Teva Pharmaceuticals USA, Inc.
$13
MorphoSys, US Inc.
$12
Karyopharm Therapeutics Inc.
$12
Spectrum Pharmaceuticals Inc.
$11
Top 3 companies account for 54.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · Abraxane · Alecensa · Avastin · BOSULIF · BRAFTOVI · Bavencio · CALQUENCE · CYRAMZA · DARZALEX · Doptelet · ELIQUIS · EPKINLY · ERLEADA · EXKIVITY · Elahere · Empaveli · Epkinly · Erivedge · Erleada · FARESTON · FASLODEX · FERAHEME · FOLOTYN · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LUMAKRAS · LYNPARZA · Lenvima · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MOVANTIK · NINLARO · Neulasta · Nplate · Nubeqa · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · Orserdu · PADCEV · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Perjeta · REBLOZYL · RYDAPT · Revlimid · SANCUSO · SANDOSTATIN · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TEPMETKO · TIBSOVO · TREANDA · TUKYSA · Tavalisse · Tivdak · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XARELTO · XPOVIO · XTANDI · Xtandi · Yescarta · ZEJULA · Zevalin · Zoladex · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
652
County median income
$114,316
Nearest hospital to ZIP centroid (approximate)
NEWTON MEDICAL CENTER
9.1 mi
9.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chatiwala is a mixed practice specialist, with above-average Medicare volume (top 0% in NJ), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chatiwala experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Chatiwala performed 51,750 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chatiwala receive payments from pharmaceutical companies?
Yes. Dr. Chatiwala received a total of $17,204 from 65 companies across 311 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chatiwala's costs compare to other internal medicine physicians in Sparta?
Dr. Chatiwala's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chatiwala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Sparta
Browse internal medicine physicians in Sparta ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
Cornerstone Specialty Network LLC Payments to Doctors
See all physicians who received payments from Cornerstone Specialty Network LLC.
By company
AMAG Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from AMAG Pharmaceuticals, Inc.
By company
Mylan Institutional Inc. Payments to Doctors
See all physicians who received payments from Mylan Institutional Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology